Labocanna

Labocanna FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Labocanna (LCN.WA) as of Oct 17, 2026 is 122.31 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 276.95 % — a change of -55.84% (lower).

FCF Conversion

122.31 %

YoY

-55.84%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Labocanna is 2025 122.31 % . FCF Conversion Rate (FCF/EBITDA) of Labocanna was 2024 276.95 % . It decreases by -55.84% lower compared to the previous year.

The Labocanna FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
35.85 PLN
Jan 1, 2019
-8.33 PLN
Jan 1, 2020
0.00 PLN
Jan 1, 2021
769.62 PLN
Jan 1, 2022
115.28 PLN
Jan 1, 2023
359.20 PLN
Jan 1, 2024
276.95 PLN
Jan 1, 2025
122.31 PLN
The Labocanna FCF Conversion history
YEARFCF ConversionYoY
122.31 %-55.84%
276.95 %-22.90%
359.20 %+211.59%
115.28 %-85.02%
769.62 %—
0.00-100.00%
-8.33 %-123.25%
35.85 %-62.79%
96.33 %-1,041.90%
-10.23 %-81.40%
-55.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Labocanna Stock analysis

What does Labocanna do? Labocanna SA is a pharmaceutical company based in Koszalin, Poland, operating within the Health Care sector. The company's primary focus is on the hemp business, as indicated by its operational description. It completed its initial public offering (IPO) on July 4, 2011, marking its entry into the public market. Labocanna SA is listed under the ticker symbol LCN.WA and holds the ISIN code PLCCTLS00017. The company's headquarters are located in Koszalin, a city in the West Pomeranian Voivodeship (Woj. Zachodniopomorskie) of Poland. Its official website is https://labocanna.pl/, which serves as a primary source of information about its operations and offerings. The company operates within the pharmaceutical industry, though specific details about its products, services, or market position are not provided in the available information. Labocanna SA's activities are centered around the hemp sector, which may include the development, production, or distribution of hemp-related products, though the exact nature of these activities remains unspecified. The company's public listing and headquarters location are key identifiers for its operational and financial profile. No additional details regarding founding year, key personnel, acquisitions, or financial figures are included in the provided data. Labocanna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Labocanna stock

FCF Conversion Rate (FCF/EBITDA) of Labocanna is 122.31 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Labocanna changed from 276.95 % to 122.31 %, representing a -55.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Labocanna since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Labocanna with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Labocanna

All Key Metrics — Labocanna